AiCuris Presents Preclinical and Phase 1 Data of its anti-HSV drug AIC316

AiCuris announced today the presentation of preclinical and Phase 1 data on AIC316 at the Antivirals Congress in Amsterdam, Netherlands, from 7th – 9th of November 2010. AIC316 is a novel anti-HSV drug currently in clinical phase 2 testing.
AiCuris scientist and project leader Dr. Alexander Birkmann will give an overview on the pharmacokinetic-pharmacodynamic relationship of AIC316 by presenting efficacy data from experiments performed in a murine infection model and Phase 1 pharmacokin

Rohmert and Goetzelmann found joint consultation company

Rohmert and Goetzelmann found joint consultation company

Frankfurt am Main, 03 November 2010 – Werner Rohmert and Jochen Goetzelmann have teamed up to establish a new consultation company in the real estate industry – Targacom Advisory GmbH.

Targacom Advisory develops efficient communication strategies for real estate companies which include, as you would expect, the increased merging of the various fields of communication as well as orienting the real estate industry more towards the capital market and transnational investment activities. The interd